At a glance
ClinicalIndex Comparison RecordN/ACompleted· 74 enrolled
Drug / intervention
OCS Liver Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Continued Access Protocol To Evaluate the Effectiveness of the Portable Organ Care System (OCS) Liver for Preserving and Assessing Donor Livers for Transplantation.
In Brief
A clinical study evaluating OCS Liver System for Liver Transplant. Completed, enrolled 74 participants across 17 sites.
Detailed Summary
Continued Access Protocol to evaluate the effectiveness of the OCS Liver System to preserve and assess donor livers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Transplant
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedDec 2019
Enrollment StartFeb 2020
Primary CompletionFeb 2021
Study CompletionFeb 2023
TodayJul 2026
First PostedDec 4, 2019
Enrollment StartFeb 3, 2020
Primary CompletionFeb 2, 2021
Study CompletionFeb 2, 2023
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 6.6 years ago
Interventions
OCS Liver Systemdevice
OCS Liver System for preserving and assessing donor livers for transplantation